Lexicon Pharmaceuticals Inc
LXRX1.230USD
0.000
Close 12/26, 16:00（ET）Quotes delayed by 15 min
446.98MMarket Cap
LossP/E TTM
Lexicon Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
31.08M
2481.48%
EPS(YoY)
-0.63
21.82%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 31.08M, with a year-on-year change of 2481.48%.
What is the Earnings Per Share (EPS) of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.626, with a year-on-year change of 21.82%.
What is the net income of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its net income was -200.40M, with a year-on-year change of -13.15%.
What is the net margin of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was -644.78%, with a year-on-year change of 95.62%.
What is the gross margin of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 98.02%, with a year-on-year change of 5.46%.
What is the debt-to-asset ratio of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 33.61%, with a year-on-year change of -22.51%.
What is the Return on Equity (ROE) of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -167.66%, with a year-on-year change of 0.50%.
What is the Return on Assets (ROA) of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -75.93%, with a year-on-year change of 9.17%.
What is the operating profit of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -197.12M, with a year-on-year change of -14.77%.
What are the current assets of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its current assets were 246.19M, with a year-on-year change of 39.45%.
What are the total assets of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its total assets of Lexicon Pharmaceuticals Inc were 298.42M, with a year-on-year change of 30.07%.
What are the total liabilities of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Lexicon Pharmaceuticals Inc were 152.47M, with a year-on-year change of 11.85%.
What is the total equity of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its total equity of Lexicon Pharmaceuticals Inc was 145.95M, with a year-on-year change of 56.75%.
What is the net operating income of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Lexicon Pharmaceuticals Inc was -200.40M, with a year-on-year change of -13.15%.
What is the net investment of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its net investment of Lexicon Pharmaceuticals Inc was -15.38M, with a year-on-year change of 69.21%.
What is the net financing of Lexicon Pharmaceuticals Inc?
According to Lexicon Pharmaceuticals Inc's FY2024 earnings report, its net financing of Lexicon Pharmaceuticals Inc was 238.35M, with a year-on-year change of 26.81%.
